Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Scilex Holding Company ( (SCLX) ) has shared an announcement.
On September 25, 2025, Scilex Holding Company announced a $150 million Bitcoin investment in Datavault AI Inc. to accelerate its supercomputing infrastructure and expand data exchanges. This strategic move aims to capture growth in the biotech data monetization market, leveraging Scilex’s expertise in the biotech sector. The agreement involves Scilex purchasing a significant number of Datavault shares, with the potential for Scilex to nominate directors to Datavault’s board, indicating a deepening relationship between the two companies.
The most recent analyst rating on (SCLX) stock is a Buy with a $770.00 price target. To see the full list of analyst forecasts on Scilex Holding Company stock, see the SCLX Stock Forecast page.
More about Scilex Holding Company
Scilex Holding Company is a revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for treating acute and chronic pain, as well as neurodegenerative and cardiometabolic diseases. They aim to address high unmet needs with non-opioid therapies and have a range of commercial products including ZTlido, ELYXYB, and Gloperba.
Average Trading Volume: 233,494
Technical Sentiment Signal: Buy
Current Market Cap: $198.9M
For a thorough assessment of SCLX stock, go to TipRanks’ Stock Analysis page.